Is the business good?
How good a business is TMDX?
TransMedics Group, Inc. keeps 15% of every revenue dollar as operating profit, against 11% for the median Medical Devices name.
15%
Operating margin · Medical Devices median 11% · 12 months to Q1 2026
- Cash conversion
- 0.88×
Cash conversion · −1.29× a year ago · some of the reported profit has not turned into cash yet
- Share count, year on year
- −9.3%
Share count, year on year · bought back, each share owns more of the company
- R&D as % of revenue
- 12%
R&D as % of revenue
| Year | Operating margin |
|---|---|
| FY2020 | −103% |
| FY2021 | −130% |
| FY2022 | −34% |
| FY2023 | −12% |
| FY2024 | 8.5% |
| FY2025 | 18% |
Details›
- Gross margin12 months to Q1 2026
- 59%
- Operating margin12 months to Q1 2026
- 15%
- Net margin12 months to Q1 2026
- 27%
- Free cash flow margin
- 24%
- R&D as % of revenue
- 12%
- Revenue, trailing twelve months
- $636M
- Free cash flow, trailing twelve months
- $151M
- Net income, trailing twelve months
- $172M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion from the cash flow statement.